Jacquinot Q; Federatif du Cancer de Franche-Comte, Besancon, France
Meneveau N; Falcoz A; Roux P;et al
European journal of physical & rehabilitation medicine.. 62(5):537-544,
BACKGROUND: Physical exercise is increasingly recognized as an effective
non-pharmacological intervention to mitigate treatment-related adverse
effects in cancer patients. However, evidence remains limited regarding
the benefits of structured exercise programs in HER2-positive breast
cancer patients treated exclusively with trastuzumab.
AIM: To investigate the impact of a 3-month supervised, tailored exercise
program on fatigue and cardiorespiratory fitness in this population.
DESIGN: Phase II, randomized, prospective, multicenter trial.
SETTING: Outpatient oncology centers.
POPULATION: Eighty-nine women with HER2-positive breast cancer receiving
adjuvant trastuzumab.
METHODS: Participants were randomly assigned to a training group (TG)
undergoing 36 supervised intermittent aerobic exercise sessions (55
minutes/session, 3 days/week, combining moderate and high intensities) or
to a control group (CG) receiving usual care. Cardiopulmonary exercise
testing and fatigue assessments (MFI-20) were conducted at baseline (T0),
3 months (T3), and 6 months (T6) post-intervention.
RESULTS: At T3, TG showed clinically meaningful improvements in peak
oxygen uptake (+2.6 mL/min/kg; 95% CI: 1.8-3.4), oxygen pulse (+0.7
mL/beat), and maximal power output (+21.3 W). Ventilatory thresholds (VT)
occurred at higher workloads with reduced heart rate and respiratory rate
at submaximal intensities, indicating improved aerobic efficiency. Scores
for general fatigue, physical fatigue, and reduced activity significantly
decreased, although these changes did not reach the minimal clinically
important difference. Moderate negative correlations were observed between
fatigue scores and VO2 at VT1 and VO2 peak, suggesting that improved
fitness may alleviate fatigue.
CONCLUSIONS: A tailored, supervised exercise program significantly
enhances cardiorespiratory fitness and reduces fatigue symptoms in
HER2-positive breast cancer patients treated with trastuzumab.
Specifically, a clinically meaningful increase in peak VO2, maximal power
output, and oxygen pulse was observed, along with significant reductions
in general fatigue, physical fatigue, and reduced activity scores.
CLINICAL REHABILITATION IMPACT: Incorporating supervised, individualized
exercise into standard oncology care improves functional capacity and
fatigue management, supporting its integration into rehabilitation
programs for this population.